Actinomycin D
Term · Oncology and biomedicine · MLC-T-ONC-000187
A drug that comes from the bacterium Streptomyces parvulus and is used alone or with other drugs to treat adults and children with Ewing sarcoma, gestational trophoblastic tumor, rhabdomyosarcoma, Wilms tumor, or certain types of testicular cancer and adults with certain types of solid tumors. It is also being studied in the treatment of other types of cancer. Actinomycin D damages the cell’s DNA and may kill cancer cells. It is a type of antineoplastic antibiotic. Also called Cosmegen and dactinomycin.
| Identifier | MLC-T-ONC-000187 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Cosmegen; dactinomycin |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000187",
"term": "Actinomycin D",
"field": "Oncology and biomedicine",
"definition": "A drug that comes from the bacterium Streptomyces parvulus and is used alone or with other drugs to treat adults and children with Ewing sarcoma, gestational trophoblastic tumor, rhabdomyosarcoma, Wilms tumor, or certain types of testicular cancer and adults with certain types of solid tumors. It is also being studied in the treatment of other types of cancer. Actinomycin D damages the cell’s DNA and may kill cancer cells. It is a type of antineoplastic antibiotic. Also called Cosmegen and dactinomycin.",
"synonyms": [
"Cosmegen",
"dactinomycin"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/actinomycin-d/"
}
Record 308 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.